This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SPOKANE, Wash., March 18, 2014 (GLOBE NEWSWIRE) -- Ambassadors Group, Inc. (Nasdaq:EPAX), a leading provider of educational travel experiences, today announced that Directors Daniel G. Byrne and Timothy M. Walsh have informed the Company that they will not stand for reelection to the Board of Directors at the Company's 2014 Annual Meeting of Stockholders.
James Kalustian, Chairman of the Board of Directors stated, "I want to thank Dan and Tim for their leadership and their commitment to both the Company and its mission over their years of service. Both have assumed new executive leadership roles in their professional careers and we wish them well in their future endeavors."
The Nominating Committee of the Board of Directors had previously solicited interest in potential board member positions and interviewed several candidates. The Board's Nominating Committee and current Directors unanimously agreed to nominate existing Directors Debra Dulsky, James M. Kalustian, Peter H. Kamin, Lisa Rapuano, and Ricardo L. Valencia to fill five positions of the proposed Board slate at the Company's 2014 Annual Meeting of Stockholders. In addition, the Nominating Committee and current Directors unanimously agreed to nominate Jefferson Gramm, a principal at Bandera Partners, LLC, and Philip B. Livingston, Former Chief Executive Officer, LexisNexis Web Based Marketing Solutions, to fill the other two positions of the proposed Board slate in its upcoming proxy filing. Bandera Partners, LLC owns 3,051,697 shares of Ambassadors Group, Inc. or approximately 18 percent of the Company's outstanding shares. The Board of Directors has unanimously agreed to nominate these seven individuals, all of whom have consented to serve, as the Company's slate of directors at the upcoming 2014 Annual Meeting of Stockholders. The Company expects to receive all information and consents from the nominees necessary to satisfy the Company's Security Exchange Act disclosure obligations prior to filing its forthcoming definitive proxy statement on Schedule 14A.